These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery. Lazartigues E; Lawrence AJ; Lamb FS; Davisson RL Circ Res; 2004 Sep; 95(5):523-31. PubMed ID: 15284190 [TBL] [Abstract][Full Text] [Related]
3. Effect of aging on the renin angiotensin system in patients with renovascular hypertension. Morishita R; Higaki J; Mikami H; Matsukawa N; Ogihara T Methods Find Exp Clin Pharmacol; 1992; 14(1):17-21. PubMed ID: 1619967 [TBL] [Abstract][Full Text] [Related]
4. Hypertension, angiotensin II, and oxidative stress. Sowers JR N Engl J Med; 2002 Jun; 346(25):1999-2001. PubMed ID: 12075063 [No Abstract] [Full Text] [Related]
5. [Renin-angiotensin system and the pathogenesis of arterial hypertension]. Schiffrin EL; GarcĂa R; Boucher R; Genest J Medicina (B Aires); 1979; 39(5):674-84. PubMed ID: 232741 [No Abstract] [Full Text] [Related]
6. [Angiotensin I, angiotensin II, angiotensin III]. Arita M Nihon Rinsho; 2005 Aug; 63 Suppl 8():564-7. PubMed ID: 16149578 [No Abstract] [Full Text] [Related]
7. Influences of angiotensin on renal function in renal vascular hypertension. Ploth DW Kidney Int Suppl; 1990 Nov; 30():S97-101. PubMed ID: 2259086 [TBL] [Abstract][Full Text] [Related]
8. Role of dopamine in the striatum, renin-angiotensin system and renal sympathetic nerve on the development of two-kidney, one-clip Goldblatt hypertension. Sawamura T; Nakada T J Urol; 1996 Mar; 155(3):1108-11. PubMed ID: 8583574 [TBL] [Abstract][Full Text] [Related]
9. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease. Raij L Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551 [TBL] [Abstract][Full Text] [Related]
10. Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats. Kuczera M; Hilgers KF; Lisson C; Ganten D; Hilgenfeldt U; Ritz E; Mann JF J Hypertens; 1991 Jan; 9(1):41-8. PubMed ID: 1848258 [TBL] [Abstract][Full Text] [Related]
11. Detection and treatment of renovascular disease: 40 years on. Semple PF; Dominiczak AF J Hypertens; 1994 Jul; 12(7):729-34. PubMed ID: 7963500 [No Abstract] [Full Text] [Related]
12. Angiotensin II and neurohumoral control of the renal medullary circulation. Evans RG; Head GA; Eppel GA; Burke SL; Rajapakse NW Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):e58-69. PubMed ID: 19566838 [TBL] [Abstract][Full Text] [Related]
13. Cardiac consequences of aldosterone excess in human hypertension. Rossi GP Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183 [No Abstract] [Full Text] [Related]
14. Pharmacologic probes to identify patients with renovascular hypertension. Sosa RE; Vaughan ED Semin Urol; 1985 Nov; 3(4):317-24. PubMed ID: 2887024 [TBL] [Abstract][Full Text] [Related]